Handelsbanken Fonder Ab Intercept Pharmaceuticals, Inc. Transaction History

Handelsbanken Fonder Ab

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$14.28 - $19.53 $187,996 - $257,112	-13,165 Closed	0 $0
Q2 2021 Aug 03, 2021	BUY	$15.46 - $24.5 $203,530 - $322,542	13,165 New	13,165 $263,000
Q3 2020 Nov 13, 2020	SELL	$39.09 - $53.44 $186,263 - $254,641	-4,765 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$46.7 - $92.04 $222,525 - $438,570	4,765 New	4,765 $228,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

Stay updated on Handelsbanken Fonder Ab with notifications on news.